Clinical, Histopathological, and Molecular Characteristics of Papillary Thyroid Microcarcinoma
- 1 September 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 17 (9), 883-888
- https://doi.org/10.1089/thy.2007.0001
Abstract
Background: Papillary thyroid microcarcinoma (PTMC) detection has been increasing explosively with the recent improvement and application of new diagnostic tools. However, the associations between clinical, histopathological, and molecular findings are often not fully evaluated in reaching a decision for the treatment of PTMC. Objective: To retrospectively evaluate the patients diagnosed with PTMC in terms of the clinical and histopathological features and the immunohistochemical findings of specific molecular markers, and thereby provide an association with the disease prognosis for the Korean patients. Design: We have reviewed the clinical records of patients who underwent surgery for thyroid cancer (during January 2000 to August 2006 interval) at St. Mary's Hospital, Seoul, Korea. The clinical and histopathological characteristics of 217 PTMCs were evaluated cross-sectionally after surgery, and immunohistochemical staining of p53, epidermal growth factor receptor (EGFR), Ki-67, and cyclooxygenase-2 (COX-2) for 87 isolated specimens was performed. Main outcome: The proportions of extrathyroid extension, lymphatic invasion, and lymph node metastasis cited were 31.9%, 19.2%, and 17.8%, respectively. However, distant metastasis was not noted. Fifty-three (27.1%) patients had multiplicity, and 39 patients (20.0%) had bilateral disease. A primary tumor larger than 5 mm was significantly associated with extrathyroid extension, lymphatic invasion, and lymph node metastasis. The absence of EGFR expression shown by immunohistochemical analysis was closely correlated with extrathyroid extension and lymph node metastasis, while the absence of COX-2 expression was associated with multiplicity and bilaterality. Conclusion: Many patients with PTMC had clinical and histopathological poor prognostic factors. The expression of molecular markers, such as EGFR and COX-2, may have a role in the prognosis of PTMC. When considering all of the prognostic factors, a more tailored management approach appears to be necessary for patients with PTMC.Keywords
This publication has 32 references indexed in Scilit:
- Managing Small Thyroid CancersJAMA, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Frequent, Aggressive Behaviors of Thyroid Microcarcinomas in Korean PatientsEndocrine Journal, 2006
- Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer CommitteeThyroid®, 2004
- Prevalence, Clinical and Ultrasonographic Characteristics of Thyroid IncidentalomasThyroid®, 2004
- Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocalityCancer, 2003
- Biologic basis for the treatment of microscopic, occult well-differentiated thyroid cancerSurgery, 2001
- Extracapsular invasion of lymph node metastasisCancer, 1999
- Microcarcinoma of the thyroid glandCancer, 1998
- Occult papillary carcinoma of the thyroid. A “normal” finding in finland. A systematic autopsy studyCancer, 1985